Search research articles
Contact Us
Filters
Showing results (271-280 of 303) with videos related to
Page
of 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
Eun Ji Lee, Ji Ae Ko, Min-Je Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer
Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.
Oncotarget
|
May 7, 2017
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences
Minho Cho, Soomin Ahn, Mineui Hong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects
In Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity
Tae Hee Hong, Hongui Cha, Joon Ho Shim, et al.
The Lancet. Oncology
|
December 24, 2011
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor
Yeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial
Yeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.
Ebiomedicine
|
March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer
Sehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
World Journal of Gastroenterology
|
April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma
Min-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 303) with videos related to
Sort By:
Page
of 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC
Eun Ji Lee, Ji Ae Ko, Min-Je Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer
Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.
Oncotarget
|
May 7, 2017
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences
Minho Cho, Soomin Ahn, Mineui Hong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects
In Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity
Tae Hee Hong, Hongui Cha, Joon Ho Shim, et al.
The Lancet. Oncology
|
December 24, 2011
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor
Yeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial
Yeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.
Ebiomedicine
|
March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer
Sehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
World Journal of Gastroenterology
|
April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma
Min-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
Page
of 31